A strategic investment! The project, which represents an investment of nine million euros, was launched in July 2021. With the delivery of the first equipment in May 2022, the installation was completed in a very short time, between March and July 2022.

The production unit meets the most stringent international quality standards, in particular the European requirements of annex 1 for the manufacture of sterile medicinal products for human and veterinary use.

Philippe Astruc, Director of Industrial Operations, France, comments: "This project secures our vaccine supply chain, meets regulatory requirements, ensures high product quality and guarantees our HSE standards. This new facility is a collective success: without the mobilization, commitment and multidisciplinary skills of our teams, nothing would have been possible".

Commissioning of the new filling line
The new vaccine vial filling line is now operational. Capable of filling up to 21,000 vials per hour of liquid vaccines, it represents a significant technological advance in the production of our veterinary vaccines.

All factory and field acceptance tests have been successfully completed. Validation cycles for the vaccines and their diluents are complete and compliant. We now have a tool that will enable us to best meet the growing demand for our range of pet vaccines. 

Frédéric Castillo, Director of the Vaccine Formulation Business Unit: "With the commissioning of this new filling line, we are taking a strategic step forward in our project to build a global center of excellence in Carros for the production of biological products for veterinary use.”

This project also reflects our long-standing priority of prevention, of which vaccination is one of the main pillars. By protecting animals from potentially fatal diseases, prevention helps them live healthier lives. Vaccination contributes to the rational use of curative treatments and forms the basis of global health security so that we can all live better together.